Medpace increases credit facility to $250M and expands share buyback by $200M

Medpace Holdings, Inc.

Amendment No. 4 raises line of credit from $50M to $250M with PNC Bank, maturing March 31, 2023.
Board approved $200M increase to stock repurchase program; 1,782,136 shares repurchased since Feb 11, 2022.
Repurchases reduced outstanding shares by ~5%; 33,723,904 shares outstanding as of March 14, 2022.
Interest options include Base Rate or Term SOFR +1.00%; anti-money laundering compliance updated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.